Vemircopan

Overview

Vemircopan (ALXN2050) is an orally active complement factor D ( FD ) inhibitor. Vemircopan can be used in the research of diseases such as myasthenia gravis, lupus nephritis, IgA nephropathy, and paroxysmal nocturnal hemoglobinuria.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Complement System | Products > Signaling Pathways > Interleukin Related

Product Information

• Catalog No.: HY-139588
• CAS No.: 2086178-00-7
• Molecular Formula: C29H28BrN7O3
• Molecular Weight: 602.48
• Purity: 98.61%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 1 mg/mL (1.66 mM); Clear solution
• Availability: In-stock

Source

Original product source